Publications
Detailed Information
VEGF polymorphisms in early cervical cancer susceptibility, angiogenesis, and survival
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Yun Hwan | - |
dc.contributor.author | Kim, Min A. | - |
dc.contributor.author | Park, In-Ae | - |
dc.contributor.author | Park, Woong-Yang | - |
dc.contributor.author | Kim, Seung Cheol | - |
dc.contributor.author | Song, Yong-Sang | - |
dc.contributor.author | Kong, Soon-Beom | - |
dc.contributor.author | Park, Noh-Hyun | - |
dc.contributor.author | Kim, Jae Weon | - |
dc.date.accessioned | 2012-05-31T02:06:20Z | - |
dc.date.available | 2012-05-31T02:06:20Z | - |
dc.date.issued | 2010-11 | - |
dc.identifier.citation | GYNECOLOGIC ONCOLOGY; Vol.119 2; 232-236 | ko_KR |
dc.identifier.issn | 0090-8258 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76653 | - |
dc.description.abstract | Objective. Vascular endothelial growth factor (VEGF) plays an important role in cervical carcinogenesis. We hypothesized that VEGF genetic polymorphisms may affect cancer susceptibility, angiogenesis, and survival in patients with early cervical cancer. Methods. Among 215 healthy subjects and 199 early cervical cancer patients who were treated with surgical resection, we specifically investigated four genetic polymorphisms within the VEGF gene (-2578C>A, -460 T>C, +405G>C, and +936C>T). VEGF and CD31 microvessel density (MVD) were measured using tissue microarrays constructed from 117 patients who had available tissue. Results. Risk of cervical cancer was decreased in subjects with the VEGF -2578A/A genotype (adjusted OR = 0.39, 95% CI 0.16-0.96). Angiogenesis measured by CD31 MVD was significantly decreased in patients with the VEGF +405C/C genotype and VEGF -2578C - -460T - + 405C haplotype (recessive model; adjusted OR=0.32, 95% CI 0.11-0.99, equally). Moreover, VEGF +405C/C and VEGF -2578C - 460 T - +405C haplotype were significantly related to shorter disease-free survival (adjusted HR = 3.18, 95% CI 1.13-8.94, equally) and overall survival (adjusted HR=8.86, 95% CI 1.40-56.08, equally) by multiple Cox regression analysis. Conclusion. Polymorphisms of VEGF genes may affect cancer susceptibility and survival of early cervical cancer by modulating tumor angiogenesis. Prospective study among homogeneously treated patients is warranted. (C) 2010 Elsevier Inc. All rights reserved. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | ko_KR |
dc.subject | VEGF | ko_KR |
dc.subject | Polymorphism | ko_KR |
dc.subject | Cervical cancer | ko_KR |
dc.subject | Survival | ko_KR |
dc.subject | Angiogenesis | ko_KR |
dc.title | VEGF polymorphisms in early cervical cancer susceptibility, angiogenesis, and survival | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 김윤환 | - |
dc.contributor.AlternativeAuthor | 김민아 | - |
dc.contributor.AlternativeAuthor | 박인애 | - |
dc.contributor.AlternativeAuthor | 박웅양 | - |
dc.contributor.AlternativeAuthor | 김재원 | - |
dc.contributor.AlternativeAuthor | 김승철 | - |
dc.contributor.AlternativeAuthor | 박노현 | - |
dc.contributor.AlternativeAuthor | 송용상 | - |
dc.contributor.AlternativeAuthor | 공순범 | - |
dc.identifier.doi | 10.1016/j.ygyno.2010.07.035 | - |
dc.citation.journaltitle | GYNECOLOGIC ONCOLOGY | - |
dc.description.citedreference | Randall LM, 2009, GYNECOL ONCOL, V112, P583, DOI 10.1016/j.ygyno.2008.11.013 | - |
dc.description.citedreference | Kim YT, 2009, J GYNECOL ONCOL, V20, P1, DOI 10.3802/jgo.2009.20.1.1 | - |
dc.description.citedreference | Schneider BP, 2008, BREAST CANCER RES TR, V111, P157, DOI 10.1007/s10549-007-9755-9 | - |
dc.description.citedreference | Hofmann G, 2008, J CANCER RES CLIN, V134, P591, DOI 10.1007/s00432-007-0322-x | - |
dc.description.citedreference | Heist RS, 2008, J CLIN ONCOL, V26, P856, DOI 10.1200/JCO.2007.13.5947 | - |
dc.description.citedreference | Kim JG, 2008, CLIN CANCER RES, V14, P62, DOI 10.1158/1078-0432.CCR-07-1537 | - |
dc.description.citedreference | NASR HB, 2008, CLIN CHIM ACTA, V395, P124, DOI 10.1016/j.cca.2008.05.022 | - |
dc.description.citedreference | Chen W, 2007, VIROLOGY, V367, P168, DOI 10.1016/j.virol.2007.05.030 | - |
dc.description.citedreference | Kim JG, 2007, ANN ONCOL, V18, P1030, DOI 10.1093/annonc/mdm085 | - |
dc.description.citedreference | Hefler LA, 2007, CLIN CANCER RES, V13, P898, DOI 10.1158/1078-0432.CCR-06-1008 | - |
dc.description.citedreference | Tzanakis N, 2006, J SURG ONCOL, V94, P624, DOI 10.1002/jso.20619 | - |
dc.description.citedreference | Anderson JE, 2006, DRUG RESIST UPDATE, V9, P198, DOI 10.1016/j.drup.2006.08.001 | - |
dc.description.citedreference | Lu H, 2005, CANCER RES, V65, P5015 | - |
dc.description.citedreference | Parkin DM, 2005, CA-CANCER J CLIN, V55, P74 | - |
dc.description.citedreference | Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081 | - |
dc.description.citedreference | Koukourakis MI, 2004, LUNG CANCER-J IASLC, V46, P293, DOI 10.1016/j.lungcan.2004.04.037 | - |
dc.description.citedreference | Toussaint-Smith E, 2004, ONCOGENE, V23, P2988, DOI 10.1038/sj.onc.1207442 | - |
dc.description.citedreference | Stevens A, 2003, CANCER RES, V63, P812 | - |
dc.description.citedreference | Lee IJ, 2002, INT J RADIAT ONCOL, V54, P768 | - |
dc.description.citedreference | Bosch FX, 2002, J CLIN PATHOL, V55, P244 | - |
dc.description.citedreference | Renner W, 2000, J VASC RES, V37, P443 | - |
dc.description.citedreference | Carmeliet P, 2000, NATURE, V407, P249 | - |
dc.description.citedreference | Watson CJ, 2000, CYTOKINE, V12, P1232 | - |
dc.description.citedreference | Fujiwaki R, 2000, ANTICANCER RES, V20, P1317 | - |
dc.description.citedreference | Kodama J, 1999, EUR J CANCER, V35, P485 | - |
dc.description.citedreference | Hanahan D, 1996, CELL, V86, P353 | - |
dc.description.citedreference | GUIDI AJ, 1995, J NATL CANCER I, V87, P1237 | - |
dc.description.tc | 8 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.